节点文献
土鳖虫活性组分F2-2体内抗凝药效实验
Study on Anticoagulant Activity in Vivo of Active Component F2-2 from Eupolyphaga seu Steleophaga
【摘要】 目的:以PT、APTT、TT、FIB、血小板聚集率及纤溶图参数为指标,评价土鳖虫抗凝组分F2-2的体内抗凝药效。方法:大鼠皮下注射肾上腺素5天造成急性血瘀症模型后,对模型大鼠灌胃给药土鳖虫抗凝组分F2-2,9天后对各指标进行测定。结果:与模型组相比,灌胃给药后的大鼠PT/APTT均延长、FIB含量降低、血小板聚集率与血液最大凝固程度下降,TT则无差异。结论:土鳖虫抗凝组分F2-2有良好的体内抗凝药效,其作用机制尚有待进一步研究。
【Abstract】 Prothrombin time(PT), activated partial thromboplastin time(APTT), thrombin time(TT), plasma fibrinogen(FIB), platelet aggregation rate and blood clots-fibrinolytic dynamic figure were taken as indexes in the evaluation of anticoagulant activity in vivo of active component F2-2 from Eupolyphaga seu Steleophaga. After 5 days of hypodermic injection of adrenaline, the rat model of acute blood stasis was established. Indexes were determined af-ter the model rats were treated with an intragastric administration of F2-2 for 9 days. The results showed that compared with the model group, PT/APTT was prolonged, FIB content was decreased, platelet aggregation rate and the largest of blood coagulation were declined after 9 days of intragastric administration in the model group. However,there was no difference on TT. It was concluded that the anticoagulant component F2-2 separated from E. seu Steleophaga showed favorable anticoagulant activity in vivo. However, its mechanism remained unknown and requested further researches.
【Key words】 Eupolyphaga sinensis Walker; anticoagulant component; F2-2; anticoagulant activity;
- 【文献出处】 世界科学技术-中医药现代化 ,Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology , 编辑部邮箱 ,2014年06期
- 【分类号】R285.5
- 【被引频次】54
- 【下载频次】305